Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07719192

Effects of Alternate Nostril Breathing and Bellows Breath in COPD Patients

COPD is a common respiratory disease characterized by progressive airflow obstruction, dyspnea, chronic cough, and sputum production. Alternate nostril breathing and bellows breath are pranayama-based breathing techniques that may improve respiratory function and overall well-being. This randomized clinical trial aims to compare the effects of these techniques on sputum clearance, pulmonary function tests, and quality of life in COPD patients. The study will be conducted at Punjab Institute of Cardiology using convenient sampling. Participants will be divided into two groups: Group A will perform alternate nostril breathing, while Group B will perform bellows breath exercises for 15-20 minutes daily over 3-4 weeks. Outcome measures include sputum clearance, spirometry, and quality of life questionnaires. Data will be analyzed using SPSS with significance set at p < 0.05. The study may support the use of cost-effective, noninvasive breathing techniques for improving pulmonary function and quality of life in COPD patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

10 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nimra Noor

Lahore, Punjab Province, 40100, Pakistan

Location contact

Nimra Noor Nimra Noor, MS-CPPT

CONTACT

[email protected]

03030684869

Nimra Noor, MS-CPPT

PRINCIPAL_INVESTIGATOR

About this study

The respiratory ailment known as chronic obstructive pulmonary disease (COPD) is becoming more and more common all over the world. It is characterized by a partiallyvolatile airway blockage. It is characterized by growing and ongoing dyspnea, persistent coughing and sputum production. Chronic cough and sputumare separaterisk factors for early death from COPD, and they are often closely associated withexacerbation. Alternate nostril breathing and bellows breath are two commontechnique which is based on pranyama,which is yogic practice of breath control. These techniques is utilize specific breathing pattern to in fluence the nervous system,energy flow and overall well being. The objective of this study is to findtheeffect of alternate nostril breathing and bellows breath on sputumclearance,pulmonary function test and quality of life among COPD patients. The study design will be randomized clinical trial. It will conducted at Punjab instituteof cardiology.sample size will be conducted through non-probability convenient sampling as per inclusion criteria participants will be randomly added intotwogroups. . Group A[alternate nostril breathing] and Group B[bellows breath]. bothintervention will be performed for 15 to 20 min/day for 3 to 4 weeks. Pre andpost intervention data will be collected. Outcome measures include sputumclearance,spiromter and health related quality of life questionnaire. Data will beanalyzed by using SPSS. Paired or Independent t-test will be used to comparevariables between the two groups and within the two groups, with significance set at p< 0.05. This study will provide evidence for the integration of noninvasive, cost effective strategies for the enhancement of PFT's and functional capacity and qualityof life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosed case of copd patients
  • Age group:above 10 years
  • Clinically stable
  • Able to understand or perform breathing exercise

Exclusion criteria

  • current acute pulmonary infection
  • History of pneumothorax or hemoptysis
  • Patients who was in stage 4 of functional classification of fatigue,palpation,dyspnea or anginal pain

Treatment and study plan

Alternate Nostril Breathing

Other

This technique includingstress reduction,improved respiratory health and enhanced mental clarity. Participants will then be instructed to perform this activity 15 to 20 min/day for 4 days/week for 3to 4 weeks.

bellows breath

Other

This technique drain the excess phlegm from brain. It improves awareness, focus concentration and productivity. Participants will then be instructed to performthis activity 10 to 15 min/day for 5 days/week for 3 to 4 weeks.

Primary outcomes

  1. Forced Vital Capacity

    Time frame: Baseline and after 4 weeks of intervention

    Forced Vital Capacity (FVC) will be measured in liters (L) using spirometry. FVC represents the maximum volume of air that can be forcefully exhaled after a maximal inspiration.

  2. Forced Expiratory Volume in One Second

    Time frame: Baseline and after 4 weeks of intervention

    Forced Expiratory Volume in One Second (FEV₁) will be measured in liters (L) using spirometry. FEV₁ represents the volume of air exhaled during the first second of a forced expiratory maneuver.

  3. FEV₁/FVC ratio

    Time frame: Baseline and after 4 weeks of intervention

    The FEV₁/FVC ratio will be expressed as a percentage (%) and calculated from spirometric measurements to assess the degree of airflow limitation

  4. Health-Related Quality of Life

    Time frame: Baseline and after 4 weeks of intervention

    The HRQOL (Health-Related Quality of Life) questionnaire is a tool usedtoassess an individual's overall well-being, focusing on how their health impacts their daily life. It's a 14-item questionnaire developed by the Centers for DiseaseControl and Prevention (CDC) that explores physical, mental, and social healthdomains

Study contacts

Contact information is provided by the study sponsor or research team.

Muhammad Iqbal Tariq Phd*, Phd*

CONTACT

[email protected]

333826752

Nimra noor Noor, MS

CONTACT

[email protected]

03030684869

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Effects of Alternate Nostril Breathing and Bellows Breath on Sputum Clearance, Pulmonary Function Test and Quality of Life Among COPD Patients

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 22, 2026
Registry last updated
Jul 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.